Elevated TGF-β1 levels have been consistently observed in adenomyosis patients, with experimental evidence demonstrating that TGF-β1 inhibition reduces uterine collagen accumulation and attenuates disease-associated fibrosis 61. The gene discussed is TGFB1; the disease is adenomyosis.